The 2.4 mg dose, which became the standard dose carried forward into phase 3 trials, produced approximately 8% to 9% weight loss in 26 weeks
Retatrutide falls squarely within this expected range, and at the favorable end of it
CrossRef The Serpin Superfamily in Adipose Tissue Remodeling: Molecular Drivers of ImmuneMetabolic Crosstalk and Insulin Sensitivity Nouran Alwisi, Alaa Abdelhamid, Amna Al-Quradaghi, Maha Talhami, Aldana M
Gigliotti contrasts such a patient with a person who has a BMI of 40 and diagnoses of hypertension, type 2 diabetes, CVD, and musculoskeletal issues, who may benefit from lifelong use of weight management medications
At the center of it all
With the same dosage and price, it delivers effects that can last up to 20 times longer than traditional injections